Neurochemistry of the hippocampus in patients with obsessive–compulsive disorder
Version of Record online: 15 JUN 2009
© 2009 The Authors. Journal compilation © 2009 Japanese Society of Psychiatry and Neurology
Psychiatry and Clinical Neurosciences
Volume 63, Issue 4, pages 486–490, August 2009
How to Cite
Atmaca, M., Yildirim, H., Ozdemir, H., Koc, M., Ozler, S. and Tezcan, E. (2009), Neurochemistry of the hippocampus in patients with obsessive–compulsive disorder. Psychiatry and Clinical Neurosciences, 63: 486–490. doi: 10.1111/j.1440-1819.2009.01993.x
- Issue online: 16 JUL 2009
- Version of Record online: 15 JUN 2009
- Received 22 May 2008; revised 16 March 2009; accepted 1 April 2009.
- magnetic resonance spectroscopy;
- obsessive–compulsive disorder;
Aim: To date, despite possible neuroanatomical importance, no magnetic resonance spectroscopy (MRS) study on hippocampus has been performed in obsessive–compulsive disorder (OCD). The purpose of the present study was therefore to compare hippocampal chemicals in patients with OCD with those in healthy subjects with no psychopathology.
Methods: Eighteen patients meeting DSM-IV criteria for OCD and 18 healthy controls were studied. The patients and controls underwent proton magnetic resonance spectroscopy (1H-MRS), and measures of N-acetyl-l-aspartate (NAA), choline (CHO), and creatine (CRE) in hippocampal regions were obtained.
Results: Both NAA/CRE and NAA/CHO ratios in the hippocampus in patients with OCD were reduced relative to healthy controls. The anova showed a near-significant effect of diagnosis for NAA/CRE and a significant effect for NAA/CHO, but the anova did not show any significant effect even at a trend level for CHO/CRE. No main effect of hemisphere was found for any metabolite ratio.
Conclusions: The presence of neuronal degeneration is suggested in OCD. Future longitudinal neuroimaging and neuropsychological studies with larger patient samples are warranted in order to confirm these preliminary findings to better characterize the relevance of neurochemical abnormalities in hippocampus in the pathophysiology of OCD.